fbpx
CALL US: 210-949-0122
Studies for Seniors »

by: Clinical Trials of Texas, Inc.

Seventeen years ago, men across the world received a beacon of hope in the form of Viagra, while women with low libido were left still searching for treatment.

Researchers say that women across the country may be in luck thanks to a little pink pill.

“Flibanserin has been undergoing testing in female patients for several years and studies are showing promise,” says Dr. Harry Croft of Clinical Trials of Texas.

Patients across the country are in agreement, pushing the FDA to approve the much needed treatment. One group called “Even the Score” has even launched a public relations campaign to encourage the FDA to approve the drug.

Croft, who has been involved in research studies testing flibanserin, is testifying before the FDA tomorrow in hopes of obtaining FDA approval to move forward with the potential new treatment option.

“We are hopeful that we will get approval, but you can never be certain,” says Croft.

The drug has been refused by the FDA twice in the past

The medical name for low libido, hypoactive sexual desire disorder or HSDD, has been recognized by the FDA as one of the top 20 focus areas but there are no approved medications to treat it to date.

“Buproprion and testosterone are often used off-label to try and treat HSDD, however they do not have the safety evidence that flibanserin has when it comes to treatments,” says Croft.

Croft and his colleagues at Clinical Trials of Texas are continuing to test many different treatment options for women with HSDD. To learn more about currently enrolling trials, visit SAresearch.com or call 210.949.0122.